{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:15:40Z","timestamp":1788873340912,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82103107"],"award-info":[{"award-number":["No. 82103107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82172701"],"award-info":[{"award-number":["No. 82172701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University","award":["ZYYC20002"],"award-info":[{"award-number":["ZYYC20002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10495-024-01936-7","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T11:01:57Z","timestamp":1710759717000},"page":"2183-2196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Novel CAR-T cells targeting TRKB for the treatment of solid cancer"],"prefix":"10.1007","volume":"29","author":[{"given":"Dandan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuncang","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"issue":"9","key":"1936_CR1","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","volume":"5","author":"AM Vargason","year":"2021","unstructured":"Vargason AM, Anselmo AC, Mitragotri S (2021) The evolution of commercial drug delivery technologies. Nat Biomed Eng 5(9):951\u2013967","journal-title":"Nat Biomed Eng"},{"issue":"3","key":"1936_CR2","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1016\/S1470-2045(19)30823-X","volume":"21","author":"AK Singh","year":"2020","unstructured":"Singh AK, McGuirk JP (2020) CAR T cells: continuation in a revolution of immunotherapy. Lancet Oncol 21(3):e168\u2013e178","journal-title":"Lancet Oncol"},{"issue":"1","key":"1936_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2017.156","volume":"15","author":"V Prasad","year":"2018","unstructured":"Prasad V (2018) Immunotherapy: tisagenlecleucel\u2014the first approved CAR-T-cell therapy\u2014implications for payers and policy makers. Nat Rev Clin Oncol 15(1):11\u201312","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1936_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12943-022-01663-0","volume":"21","author":"J Lu","year":"2022","unstructured":"Lu J, Jiang G (2022) The journey of CAR-T therapy in hematological malignancies. Mol Cancer 21(1):194","journal-title":"Mol Cancer"},{"issue":"2","key":"1936_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/jcp.29044","volume":"235","author":"MR Atashzar","year":"2020","unstructured":"Atashzar MR, Baharlou R, Karami J, Abdollahi H, Rezaei R, Pourramezan F, Zoljalali Moghaddam SH (2020) Cancer stem cells: a review from origin to therapeutic implications. J Cell Physiol 235(2):790\u2013803","journal-title":"J Cell Physiol"},{"issue":"12","key":"1936_CR6","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.jid.2016.07.024","volume":"136","author":"D Kumar","year":"2016","unstructured":"Kumar D, Kumar S, Gorain M, Tomar D, Patil HS, Radharani NNV, Kumar TVS, Patil TV, Thulasiram HV, Kundu GC (2016) Notch1-MAPK signaling axis regulates CD133(+) cancer stem cell-mediated melanoma growth and angiogenesis. J Invest Dermatol 136(12):2462\u20132474","journal-title":"J Invest Dermatol"},{"key":"1936_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-S1-S6","author":"W Wei","year":"2012","unstructured":"Wei W, Hu H, Tan H, Chow LW, Yip AY, Loo WT (2012) Relationship of CD44+CD24\u2212\/low breast cancer stem cells and axillary lymph node metastasis. J Trans Med. https:\/\/doi.org\/10.1186\/1479-5876-10-S1-S6","journal-title":"J Trans Med"},{"issue":"1","key":"1936_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","volume":"22","author":"KM Maalej","year":"2023","unstructured":"Maalej KM, Merhi M, Inchakalody VP, Mestiri S, Alam M, Maccalli C, Cherif H, Uddin S, Steinhoff M, Marincola FM et al (2023) CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Mol Cancer 22(1):20","journal-title":"Mol Cancer"},{"issue":"12","key":"1936_CR9","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","volume":"15","author":"E Cocco","year":"2018","unstructured":"Cocco E, Scaltriti M, Drilon A (2018) NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol 15(12):731\u2013747","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"1936_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.stem.2018.03.011","volume":"22","author":"X Wang","year":"2018","unstructured":"Wang X, Prager BC, Wu Q, Kim LJY, Gimple RC, Shi Y, Yang K, Morton AR, Zhou W, Zhu Z et al (2018) Reciprocal signaling between glioblastoma stem cells and differentiated tumor cells promotes malignant progression. Cell Stem Cell 22(4):514-528.e515","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1936_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bbrc.2011.01.116","volume":"406","author":"W Jin","year":"2011","unstructured":"Jin W, Lee JJ, Kim MS, Son BH, Cho YK, Kim HP (2011) DNA methylation-dependent regulation of TrkA, TrkB, and TrkC genes in human hepatocellular carcinoma. Biochem Biophys Res Commun 406(1):89\u201395","journal-title":"Biochem Biophys Res Commun"},{"key":"1936_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317692256","author":"MD Johnson","year":"2017","unstructured":"Johnson MD, Stone B, Thibodeau BJ, Baschnagel AM, Galoforo S, Fortier LE, Ketelsen B, Ahmed S, Kelley Z, Hana A et al (2017) The significance of Trk receptors in pancreatic cancer. Tumour Biol. https:\/\/doi.org\/10.1177\/1010428317692256","journal-title":"Tumour Biol"},{"issue":"7","key":"1936_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1365-2559.2009.03308.x","volume":"54","author":"WG Foster","year":"2009","unstructured":"Foster WG, Elias R, Faghih M, Dominguez MA, Elit L, Boutross-Tadross O (2009) Immunohistochemical localization of tyrosine receptor kinases A and B in endometriosis-associated ovarian cancer. Histopathology 54(7):907\u2013912","journal-title":"Histopathology"},{"issue":"5","key":"1936_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/jso.21232","volume":"99","author":"K Tanaka","year":"2009","unstructured":"Tanaka K, Mohri Y, Nishioka J, Kobayashi M, Ohi M, Miki C, Tonouchi H, Nobori T, Kusunoki M (2009) Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients. J Surg Oncol 99(5):307\u2013310","journal-title":"J Surg Oncol"},{"issue":"10","key":"1936_CR15","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1111\/jcmm.13181","volume":"21","author":"C Mazouffre","year":"2017","unstructured":"Mazouffre C, Geyl S, Perraud A, Blondy S, Jauberteau MO, Mathonnet M, Verdier M (2017) Dual inhibition of BDNF\/TrkB and autophagy: a promising therapeutic approach for colorectal cancer. J Cell Mol Med 21(10):2610\u20132622","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1936_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.lungcan.2012.07.011","volume":"78","author":"K Okamura","year":"2012","unstructured":"Okamura K, Harada T, Wang S, Ijichi K, Furuyama K, Koga T, Okamoto T, Takayama K, Yano T, Nakanishi Y (2012) Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer. Lung Cancer 78(1):100\u2013106","journal-title":"Lung Cancer"},{"issue":"9","key":"1936_CR17","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1002\/jcb.25943","volume":"118","author":"A Tajbakhsh","year":"2017","unstructured":"Tajbakhsh A, Mokhtari-Zaer A, Rezaee M, Afzaljavan F, Rivandi M, Hassanian SM, Ferns GA, Pasdar A, Avan A (2017) Therapeutic potentials of BDNF\/TrkB in breast cancer; current status and perspectives. J Cell Biochem 118(9):2502\u20132515","journal-title":"J Cell Biochem"},{"issue":"5","key":"1936_CR18","first-page":"1364","volume":"52","author":"A Nakagawara","year":"1992","unstructured":"Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM (1992) Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Can Res 52(5):1364\u20131368","journal-title":"Can Res"},{"issue":"1","key":"1936_CR19","first-page":"37","volume":"12","author":"DJ Yamashiro","year":"1996","unstructured":"Yamashiro DJ, Nakagawara A, Ikegaki N, Liu XG, Brodeur GM (1996) Expression of TrkC in favorable human neuroblastomas. Oncogene 12(1):37\u201341","journal-title":"Oncogene"},{"issue":"5","key":"1936_CR20","first-page":"935","volume":"14","author":"P Scaruffi","year":"1999","unstructured":"Scaruffi P, Cusano R, Dagnino M, Tonini GP (1999) Detection of DNA polymorphisms and point mutations of high-affinity nerve growth factor receptor (TrkA) in human neuroblastoma. Int J Oncol 14(5):935\u2013938","journal-title":"Int J Oncol"},{"issue":"5","key":"1936_CR21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/bjc.1996.435","volume":"74","author":"M Ryd\u00e9n","year":"1996","unstructured":"Ryd\u00e9n M, Sehgal R, Dominici C, Schilling FH, Ib\u00e1\u00f1ez CF, Kogner P (1996) Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis. Br J Cancer 74(5):773\u2013779","journal-title":"Br J Cancer"},{"issue":"3","key":"1936_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","volume":"17","author":"S Rafiq","year":"2020","unstructured":"Rafiq S, Hackett CS, Brentjens RJ (2020) Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat Rev Clin Oncol 17(3):147\u2013167","journal-title":"Nat Rev Clin Oncol"},{"key":"1936_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells11010021","author":"GM Branella","year":"2021","unstructured":"Branella GM, Spencer HT (2021) Natural receptor- and ligand-based chimeric antigen receptors: strategies using natural ligands and receptors for targeted cell killing. Cells. https:\/\/doi.org\/10.3390\/cells11010021","journal-title":"Cells"},{"key":"1936_CR24","doi-asserted-by":"publisher","first-page":"1078003","DOI":"10.3389\/fimmu.2022.1078003","volume":"13","author":"A Ram\u00edrez-Chac\u00f3n","year":"2022","unstructured":"Ram\u00edrez-Chac\u00f3n A, Betriu-M\u00e9ndez S, Bartol\u00f3-Ibars A, Gonz\u00e1lez A, Mart\u00ed M, Juan M (2022) Corrigendum: ligand-based CAR T-cell\u2014different strategies to drive T-cells in future new treatments. Front Immunol 13:1078003","journal-title":"Front Immunol"},{"key":"1936_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pharmthera.2017.02.006","volume":"173","author":"YB Khotskaya","year":"2017","unstructured":"Khotskaya YB, Holla VR, Farago AF, Mills Shaw KR, Meric-Bernstam F, Hong DS (2017) Targeting TRK family proteins in cancer. Pharmacol Ther 173:58\u201366","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1936_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2009.02.025","volume":"281","author":"CW Au","year":"2009","unstructured":"Au CW, Siu MK, Liao X, Wong ES, Ngan HY, Tam KF, Chan DC, Chan QK, Cheung AN (2009) Tyrosine kinase B receptor and BDNF expression in ovarian cancers: effect on cell migration, angiogenesis and clinical outcome. Cancer Lett 281(2):151\u2013161","journal-title":"Cancer Lett"},{"issue":"12","key":"1936_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/intimm\/dxab077","volume":"33","author":"D Sugiura","year":"2021","unstructured":"Sugiura D, Shimizu K, Maruhashi T, Okazaki IM, Okazaki T (2021) T-cell-intrinsic and -extrinsic regulation of PD-1 function. Int Immunol 33(12):693\u2013698","journal-title":"Int Immunol"},{"key":"1936_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001875","author":"L Sun","year":"2021","unstructured":"Sun L, Gao F, Gao Z, Ao L, Li N, Ma S, Jia M, Li N, Lu P, Sun B et al (2021) Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in hepatocellular carcinoma. J Immuno Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-001875","journal-title":"J Immuno Cancer"},{"issue":"1","key":"1936_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1756-9966-30-97","volume":"30","author":"D Guo","year":"2011","unstructured":"Guo D, Hou X, Zhang H, Sun W, Zhu L, Liang J, Jiang X (2011) More expressions of BDNF and TrkB in multiple hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis, supressed invasion of HepG2 and HCCLM3 cells. J Exp Clin Cancer Res 30(1):97","journal-title":"J Exp Clin Cancer Res"},{"issue":"2 Pt 1","key":"1936_CR30","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/1078-0432.440.11.2","volume":"11","author":"GM Sclabas","year":"2005","unstructured":"Sclabas GM, Fujioka S, Schmidt C, Li Z, Frederick WA, Yang W, Yokoi K, Evans DB, Abbruzzese JL, Hess KR et al (2005) Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. Clin Cancer Res 11(2 Pt 1):440\u2013449","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1936_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ccell.2021.12.005","volume":"40","author":"S Heitzeneder","year":"2022","unstructured":"Heitzeneder S, Bosse KR, Zhu Z, Zhelev D, Majzner RG, Radosevich MT, Dhingra S, Sotillo E, Buongervino S, Pascual-Pasto G et al (2022) GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity. Cancer Cell 40(1):53-69.e59","journal-title":"Cancer Cell"},{"key":"1936_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012615-044438","volume":"11","author":"D Nassar","year":"2016","unstructured":"Nassar D, Blanpain C (2016) Cancer stem cells: basic concepts and therapeutic implications. Annu Rev Pathol 11:47\u201376","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"1936_CR33","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/onc.2014.8","volume":"34","author":"B Yin","year":"2015","unstructured":"Yin B, Ma ZY, Zhou ZW, Gao WC, Du ZG, Zhao ZH, Li QQ (2015) The TrkB+ cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model. Oncogene 34(6):761\u2013770","journal-title":"Oncogene"},{"issue":"10","key":"1936_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00018-023-04960-z","volume":"80","author":"MS Kim","year":"2023","unstructured":"Kim MS, Lee WS, Jin W (2023) TrkB inhibition of DJ-1 degradation promotes the growth and maintenance of cancer stem cell characteristics in hepatocellular carcinoma. Cell Mol Life Sci 80(10):303","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"1936_CR35","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1172\/JCI64057","volume":"122","author":"KH Noh","year":"2012","unstructured":"Noh KH, Kim BW, Song KH, Cho H, Lee YH, Kim JH, Chung JY, Kim JH, Hewitt SM, Seong SY et al (2012) Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Investig 122(11):4077\u20134093","journal-title":"J Clin Investig"},{"issue":"1","key":"1936_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-023-01467-9","volume":"16","author":"J Fan","year":"2023","unstructured":"Fan J, Yu Y, Yan L, Yuan Y, Sun B, Yang D, Liu N, Guo J, Zhang J, Zhao X (2023) GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer. J Hematol Oncol 16(1):77","journal-title":"J Hematol Oncol"},{"key":"1936_CR37","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008402","author":"W Wei","year":"2023","unstructured":"Wei W, Ma H, Yang D, Sun B, Tang J, Zhu Y, Chen X, Huang X, Liu J, Hu Z et al (2023) SECTM1-based CAR-T cells enriched with CD7low\/negative subsets exhibit efficacy in CD7-positive malignancies. Blood Adv. https:\/\/doi.org\/10.1182\/bloodadvances.2022008402","journal-title":"Blood Adv"},{"issue":"11","key":"1936_CR38","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1158\/2326-6066.CIR-19-0026","volume":"7","author":"B Sun","year":"2019","unstructured":"Sun B, Yang D, Dai H, Liu X, Jia R, Cui X, Li W, Cai C, Xu J, Zhao X (2019) Eradication of hepatocellular carcinoma by NKG2D-based CAR-T cells. Cancer Immunol Res 7(11):1813\u20131823","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"1936_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s40425-019-0642-9","volume":"7","author":"D Yang","year":"2019","unstructured":"Yang D, Sun B, Dai H, Li W, Shi L, Zhang P, Li S, Zhao X (2019) T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells. J Immunother Cancer 7(1):171","journal-title":"J Immunother Cancer"},{"key":"1936_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115618","volume":"258","author":"HB El-Nassan","year":"2023","unstructured":"El-Nassan HB, Al-Qadhi MA (2023) Recent advances in the discovery of tropomyosin receptor kinases TRKs inhibitors: a mini review. Eur J Med Chem 258:115618","journal-title":"Eur J Med Chem"},{"issue":"7003","key":"1936_CR41","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/nature02765","volume":"430","author":"S Douma","year":"2004","unstructured":"Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, Peeper DS (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430(7003):1034\u20131039","journal-title":"Nature"},{"key":"1936_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2407-10-43","volume":"10","author":"S Zhang","year":"2010","unstructured":"Zhang S, Guo D, Luo W, Zhang Q, Zhang Y, Li C, Lu Y, Cui Z, Qiu X (2010) TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells. BMC Cancer 10:43","journal-title":"BMC Cancer"},{"issue":"4","key":"1936_CR43","first-page":"943","volume":"37","author":"YT Huang","year":"2010","unstructured":"Huang YT, Lai PC, Wu CC, Cheng CC, Chiu TH (2010) TrkB antibody elicits cytotoxicity and suppresses migration\/invasion of transitional cell carcinoma cells. Int J Oncol 37(4):943\u2013949","journal-title":"Int J Oncol"},{"issue":"6","key":"1936_CR44","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/cam4.158","volume":"2","author":"K Kawamura","year":"2013","unstructured":"Kawamura K, Kawamura N, Okamoto N, Manabe M (2013) Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF\/TrkB signaling. Cancer Med 2(6):849\u2013861","journal-title":"Cancer Med"},{"issue":"4","key":"1936_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/1061186X.2018.1533964","volume":"27","author":"J Zou","year":"2019","unstructured":"Zou J, Zhang Z, Xu F, Cui S, Qi C, Luo J, Wang Z, Lu X, Tu Z, Ren X et al (2019) GZD2202, a novel TrkB inhibitor, suppresses BDNF-mediated proliferation and metastasis in neuroblastoma models. J Drug Target 27(4):442\u2013450","journal-title":"J Drug Target"},{"key":"1936_CR46","doi-asserted-by":"publisher","first-page":"1070961","DOI":"10.3389\/fimmu.2022.1070961","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Han J, Yang Y, Chen Y (2022) PD-1\/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy. Front Immunol 13:1070961","journal-title":"Front Immunol"},{"issue":"7","key":"1936_CR47","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.tibtech.2021.12.009","volume":"40","author":"ER Vander Mause","year":"2022","unstructured":"Vander Mause ER, Atanackovic D, Lim CS, Luetkens T (2022) Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity. Trends Biotechnol 40(7):875\u2013890","journal-title":"Trends Biotechnol"},{"issue":"5178","key":"1936_CR48","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1126\/science.8079174","volume":"265","author":"RT Dobrowsky","year":"1994","unstructured":"Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA (1994) Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265(5178):1596\u20131599","journal-title":"Science"},{"issue":"4","key":"1936_CR49","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1476-5381.2010.01094.x","volume":"162","author":"M Cazorla","year":"2011","unstructured":"Cazorla M, Arrang JM, Pr\u00e9mont J (2011) Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor. Br J Pharmacol 162(4):947\u2013960","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1936_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12943-019-1057-4","volume":"18","author":"S Yu","year":"2019","unstructured":"Yu S, Yi M, Qin S, Wu K (2019) Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity. Mol Cancer 18(1):125","journal-title":"Mol Cancer"},{"issue":"1","key":"1936_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2009.01.016","volume":"279","author":"L Qiang","year":"2009","unstructured":"Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, Liu W, Qi Q, Lu N, Tao L, Wang XT et al (2009) Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett 279(1):13\u201321","journal-title":"Cancer Lett"},{"issue":"1","key":"1936_CR52","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.canlet.2008.02.010","volume":"265","author":"SC Yu","year":"2008","unstructured":"Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH, Yao XH, Gao L, Wang JM, Bian XW (2008) Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett 265(1):124\u2013134","journal-title":"Cancer Lett"},{"issue":"6","key":"1936_CR53","first-page":"1293","volume":"9","author":"S Li","year":"2019","unstructured":"Li S, Dai Z, Yang D, Li W, Dai H, Sun B, Liu X, Xie X, Xu R, Zhao X (2019) Targeting \u03b22 subunit of Na(+)\/K(+)-ATPase induces glioblastoma cell apoptosis through elevation of intracellular Ca(2). Am J Cancer Res 9(6):1293\u20131308","journal-title":"Am J Cancer Res"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-024-01936-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-024-01936-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-024-01936-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T18:07:08Z","timestamp":1731434828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-024-01936-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":53,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1936"],"URL":"https:\/\/doi.org\/10.1007\/s10495-024-01936-7","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]},"assertion":[{"value":"7 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal experiments in this study were approved by the Animal Ethics Committee of West China Hospital, Sichuan University (ID: 20211492A).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}